CVR Medical Corp. Share Price BOERSE MUENCHEN
Equities
B3BN
CA1266321084
Biotechnology & Medical Research
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 EUR | -9.09% |
|
-9.09% | -42.31% |
Sales 2020 | - | Sales 2021 | - | Capitalization | 3.6M 3.31M 278M |
---|---|---|---|---|---|
Net income 2020 | - 0 0 | Net income 2021 | -1M -919K -77.21M | EV / Sales 2020 | - |
Net Debt 2020 | 360K 331K 27.81M | Net Debt 2021 | 434K 399K 33.5M | EV / Sales 2021 | - |
P/E ratio 2020 |
-11.5
x | P/E ratio 2021 |
-1.55
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 87.21% |
1 day | -9.09% | ||
Current month | -42.31% | ||
Current year | -42.31% |
![Extreme 0.001](/images/extremecours_fleche.png)
![Extreme 0.001](/images/extremecours_fleche.png)
![Extreme 0.001](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Michael Rhodes
CEO | Chief Executive Officer | - | 19/01/21 |
Paul S. Blunden
PSD | President | - | 19/10/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul S. Blunden
PSD | President | - | 19/10/16 |
Phillip Bendick
BRD | Director/Board Member | - | 12/02/20 |
Joseph Lynch
BRD | Director/Board Member | - | 16/02/20 |
1st Jan change | Capi. | |
---|---|---|
-34.85% | 8.68B | |
+22.77% | 3.86B | |
+13.65% | 2.43B | |
-26.46% | 1.84B | |
-11.67% | 1.73B | |
+36.95% | 1.16B | |
+49.67% | 842M | |
-9.17% | 702M | |
-10.61% | 594M |
- Stock Market
- Equities
- CVM.H Stock
- B3BN Stock